Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Dysarthria | Research

Assessment of non-progressive dysarthria: practice and attitude of speech and language therapists in Lebanon

Authors: Marwa Summaka, Hayat Harati, Salem Hannoun, Hiba Zein, Nour Koubaisy, Youssef Fares, Zeina Nasser

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

Non-progressive dysarthria is an acquired motor speech disorder resulting from neurological diseases such as stroke and traumatic brain injury. The evidence base for the assessment of non-progressive dysarthria remains limited with professional practices relying mainly on therapists’ clinical experience. Limited information on the assessment practices of Lebanese speech and language therapists (SLTs) is available. Such information is crucial for the development of adequate therapy services for clients with non-progressive dysarthria. This study aims to explore the assessment practices and attitudes of Lebanese SLTs working with adults with non-progressive dysarthria and to investigate their adherence to the framework of the World Health Organization’s International Classification of Functioning, Disability and Health (ICF).

Methods

A cross-sectional study was conducted in Lebanon between March and May 2021. Data was collected through an online survey that included information on socio-demographic characteristics, practices, and attitudes of SLTs who assess adults with non-progressive dysarthria.

Results

A total of 50 Lebanese SLTs responded to the survey. The majority of SLTs (78%) assessed clients with non-progressive dysarthria across all ICF domains. SLTs reported dissatisfaction with the available assessment tools (64%) and reliance on informal tools (84%). In addition, 68% of the SLTs suggested the crucial need for the development of Arabic formal assessments that can quantitatively evaluate dysarthria and determine severity. The survey also showed that the respondents demonstrated a preference for the use of impairment-based tools.

Conclusion

It can be concluded that the assessment practices of Lebanese SLTs, generally, follow the international trend and the recommended professional guidelines. Further research initiatives should be held to develop Arabic formal assessment tools for non-progressive dysarthria.
Appendix
Available only for authorised users
Literature
1.
Mitchell C, Bowen A, Tyson S, Butterfint Z, Conroy P. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury. Cochrane Database Syste Rev. 2017;1(1):Cd002088.
2.
Yorkston KM. Treatment efficacy. J Speech Lang Hear Res. 1996;39(5):S46–57.CrossRef
3.
Brady MC, Clark AM, Dickson S, Paton G, Barbour RS. The impact of stroke-related dysarthria on social participation and implications for rehabilitation. Disabil Rehabil. 2011;33(3):178–86.CrossRef
4.
Dickson S, Barbour RS, Brady M, Clark AM, Paton G. Patients' experiences of disruptions associated with post-stroke dysarthria. Int J Lang Commun Disord. 2008;43(2):135–53.CrossRef
5.
Mackenzie C. Dysarthria in stroke: a narrative review of its description and the outcome of intervention. Int J Speech Lang Pathol. 2011;13(2):125–36.CrossRef
6.
Mackenzie C, Bennett A, Cairney M. Active citizenship and acquired neurological communication difficulty. Disabil Rehabil. 2011;33(3):187–94.CrossRef
7.
Flowers HL, Silver FL, Fang J, Rochon E, Martino R. The incidence, co-occurrence, and predictors of dysphagia, dysarthria, and aphasia after first-ever acute ischemic stroke. J Commun Disord. 2013;46(3):238–48.CrossRef
8.
Lawrence ES, Coshall C, Dundas R, Stewart J, Rudd AG, Howard R, et al. Estimates of the prevalence of acute stroke impairments and disability in a multiethnic population. Stroke. 2001;32(6):1279–84.CrossRef
9.
10.
Arefyeva AP, Skripkina NA, Vasenina EE. [Speech disorders in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2019;119(9. Vyp. 2):32–6.
11.
Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol. 2004;3(9):547–56.CrossRef
12.
Dashtipour K, Tafreshi A, Lee J, Crawley B. Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches. Neurodegenerative Dise Manage. 2018;8(5):337–48.CrossRef
13.
Balchin R, Hersh D, Grantis J, Godfrey M. "ode to confidence": poetry groups for dysarthria in multiple sclerosis. Int J Speech Lang Pathol. 2020;22(3):347–58.CrossRef
14.
Rusz J, Vaneckova M, Benova B, Tykalova T, Novotny M, Ruzickova H, et al. Brain volumetric correlates of dysarthria in multiple sclerosis. Brain Lang. 2019;194:58–64.CrossRef
15.
Soliveri P, Piacentini S, Carella F, Testa D, Ciano C, Girotti F. Progressive dysarthria: definition and clinical follow-up. Neurol Sci. 2003;24(3):211–2.CrossRef
16.
Conway A, Walshe M. Management of non-progressive dysarthria: practice patterns of speech and language therapists in the Republic of Ireland. Int J Lang Commun Disord. 2015;50(3):374–88.CrossRef
17.
Rumbach AF, Finch E, Stevenson G. What are the usual assessment practices in adult non-progressive dysarthria rehabilitation? A survey of Australian dysarthria practice patterns. J Commun Disord. 2019;79:46–57.CrossRef
18.
Walshe M, Miller N. Living with acquired dysarthria: the speaker's perspective. Disabil Rehabil. 2011;33(3):195–203.CrossRef
19.
World Health O. ICF : international classification of functioning, disability and health / World Health Organization. Geneva: World Health Organization; 2001.
20.
Dykstra AD, Hakel ME, Adams SG. Application of the ICF in reduced speech intelligibility in dysarthria. Semin Speech Lang. 2007;28(4):301–11.CrossRef
21.
Miller N, Bloch S. A survey of speech-language therapy provision for people with post-stroke dysarthria in the UK. Int J Lang Commun Disord. 2017;52(6):800–15.CrossRef
22.
Geddes JM, Fear J, Tennant A, Pickering A, Hillman M, Chamberlain MA. Prevalence of self reported stroke in a population in northern England. J Epidemiol Community Health. 1996;50(2):140–3.CrossRef
23.
O'Mahony PG, Thomson RG, Dobson R, Rodgers H, James OF. The prevalence of stroke and associated disability. J Public Health Med. 1999;21(2):166–71.CrossRef
24.
Murdoch BE, Theodoros DG. Traumatic brain injury: associated speech, language, and swallowing disorders. San Diego: Singular/Thomson Learning; 2001.
25.
Lahoud N, Salameh P, Saleh N, Hosseini H. Prevalence of Lebanese stroke survivors: a comparative pilot study. J Epidemiol Glob Health. 2016;6(3):169–76.CrossRef
26.
Abou-Abbass H, Bahmad H, Ghandour H, Fares J, Wazzi-Mkahal R, Yacoub B, et al. Epidemiology and clinical characteristics of traumatic brain injury in Lebanon: a systematic review. Medicine. 2016;95(47):e5342.CrossRef
27.
Williams JR. The declaration of Helsinki and public health. Bull World Health Organ. 2008;86(8):650–2.CrossRef
28.
Auzou P, Rolland-Monnoury V. BECD : batterie d'évaluation clinique de la dysarthrie 2006.
29.
Enderby PM, Palmer R, Pro E. FDA-2 : Frenchay Dysarthria Assessment : Examiner's Manual. Austin, TX: Pro-Ed; 2008.
30.
Enderby PM. Frenchay Dysarthria assessment. San Diego, Calif: College-Hill Press, [1983] ©1983; 1983.
31.
Knuijt S, Kalf J, Van Engelen B, de Swart B, Geurts A. The Radboud Dysarthria Assessment: Development and Clinimetric Evaluation 2017. 143–53 p.
32.
Khalaf M, Matar N. Translation and transcultural adaptation of the VHI-10 questionnaire: the VHI-10lb. Eur Arch Otorhino-laryngol. 2017;274(8):3139–45.CrossRef
33.
Coster WJ. Making the best match: selecting outcome measures for clinical trials and outcome studies. Am J Occup Ther. 2013;67(2):162–70.CrossRef
34.
Clark HM. Neuromuscular treatments for speech and swallowing. Am J Speech Lang Pathol. 2003;12(4):400–15.CrossRef
35.
Kent RD. Nonspeech Oral movements and Oral motor disorders: a narrative review. Am J Speech Lang Pathol. 2015;24(4):763–89.CrossRef
36.
Mackenzie C, Muir M, Allen C, Jensen A. Non-speech oro-motor exercises in post-stroke dysarthria intervention: a randomized feasibility trial. Int J Lang Commun Disord. 2014;49(5):602–17.CrossRef
37.
Ziegler W. Task-related factors in Oral motor control: speech and Oral Diadochokinesis in dysarthria and apraxia of speech. Brain Lang. 2002;80(3):556–75.CrossRef
38.
Walshe M, Peach RK, Miller N. Dysarthria impact profile: development of a scale to measure psychosocial effects. Int J Lang Commun Disord. 2009;44(5):693–715.CrossRef
39.
Baylor CR, Yorkston KM, Eadie TL, Miller RM, Amtmann D. Developing the communicative participation item bank: Rasch analysis results from a spasmodic dysphonia sample. J Speech Lang Hear Res. 2009;52(5):1302–20.CrossRef
40.
Collis J, Bloch S. Survey of UK speech and language therapists' assessment and treatment practices for people with progressive dysarthria. Int J Lang Commun Disord. 2012;47(6):725–37.CrossRef
41.
Kuschmann A, Nayar R, Lowit A, Dunlop M. The use of technology in the management of children with phonological delay and adults with acquired dysarthria: a UK survey of current speech-language pathology practice. Int J Speech Langage Pathol. 2020;23:1–10.
Metadata
Title
Assessment of non-progressive dysarthria: practice and attitude of speech and language therapists in Lebanon
Authors
Marwa Summaka
Hayat Harati
Salem Hannoun
Hiba Zein
Nour Koubaisy
Youssef Fares
Zeina Nasser
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Dysarthria
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02484-2

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue

Research

Evaluation of the response to electric pulp testing in multiple sclerosis patients without a history of trigeminal neuralgia: a case-control study

Research

Initial experience with novel CGRP-receptor inhibitor therapy in Migraine in the United Arab Emirates: a retrospective observational study

Research article

Reduction in circulating vitamin D binding protein in patients with multiple sclerosis

Research article

Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey

Research

Endovascular Thrombectomy preceded by intravenous Alteplase versus endovascular Thrombectomy alone in Han Chinese patients treated for acute ischemic stroke with large vessel occlusion: a single-center retrospective analysis

Research

Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study